Endocytosis triggers V-ATPase-SYK–mediated priming of cGAS activation and innate immune response

Yu-Lin Yang(Wuhan University), Ming‐Ming Hu(Wuhan University), Li Zhong(New York University), Hong‐Bing Shu(Wuhan University), Yi Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Yang(Guangzhou University of Chinese Medicine), Li-Bo Cao(Wuhan University), Wen-Rui He(Zhengzhou University)
Proceedings of the National Academy of Sciences
October 17, 2022
10.1073/pnas.2207280119
Cited by 24

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
SIKE is an IKKε/TBK1‐associated suppressor of TLR3‐ and virus‐triggered IRF‐3 activation pathways
|The EMBO Journal|2005|157
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156